Moher D - Search Results

1

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials.

Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S; CONSORT Harms Group. Junqueira DR, et al. Among authors: moher d. J Clin Epidemiol. 2023 Jun;158:149-165. doi: 10.1016/j.jclinepi.2023.04.005. Epub 2023 Apr 24. J Clin Epidemiol. 2023. PMID: 37100738 Free article.

2

A comparison of the quality of Cochrane reviews and systematic reviews published in paper-based journals.

Shea B, Moher D, Graham I, Pham B, Tugwell P. Shea B, et al. Among authors: moher d. Eval Health Prof. 2002 Mar;25(1):116-29. doi: 10.1177/0163278702025001008. Eval Health Prof. 2002. PMID: 11868441

3

Should meta-analysts search Embase in addition to Medline?

Sampson M, Barrowman NJ, Moher D, Klassen TP, Pham B, Platt R, St John PD, Viola R, Raina P. Sampson M, et al. Among authors: moher d. J Clin Epidemiol. 2003 Oct;56(10):943-55. doi: 10.1016/s0895-4356(03)00110-0. J Clin Epidemiol. 2003. PMID: 14568625

4

Determining the reporting quality of RCTs in clinical pharmacology.

Mills E, Loke YK, Wu P, Montori VM, Perri D, Moher D, Guyatt G. Mills E, et al. Among authors: moher d. Br J Clin Pharmacol. 2004 Jul;58(1):61-5. doi: 10.1111/j.1365-2125.2004.2092.x. Br J Clin Pharmacol. 2004. PMID: 15206994 Free PMC article.

5

Better reporting of harms in randomized trials: an extension of the CONSORT statement.

Ioannidis JP, Evans SJ, Gøtzsche PC, O'Neill RT, Altman DG, Schulz K, Moher D; CONSORT Group. Ioannidis JP, et al. Among authors: moher d. Ann Intern Med. 2004 Nov 16;141(10):781-8. doi: 10.7326/0003-4819-141-10-200411160-00009. Ann Intern Med. 2004. PMID: 15545678 Free article.

6

For randomized controlled trials, the quality of reports of complementary and alternative medicine was as good as reports of conventional medicine.

Klassen TP, Pham B, Lawson ML, Moher D. Klassen TP, et al. Among authors: moher d. J Clin Epidemiol. 2005 Aug;58(8):763-8. doi: 10.1016/j.jclinepi.2004.08.020. J Clin Epidemiol. 2005. PMID: 16018911

7

Systematic reviews involving complementary and alternative medicine interventions had higher quality of reporting than conventional medicine reviews.

Lawson ML, Pham B, Klassen TP, Moher D. Lawson ML, et al. Among authors: moher d. J Clin Epidemiol. 2005 Aug;58(8):777-84. doi: 10.1016/j.jclinepi.2004.08.022. J Clin Epidemiol. 2005. PMID: 16018912

8

Language of publication restrictions in systematic reviews gave different results depending on whether the intervention was conventional or complementary.

Pham B, Klassen TP, Lawson ML, Moher D. Pham B, et al. Among authors: moher d. J Clin Epidemiol. 2005 Aug;58(8):769-76. doi: 10.1016/j.jclinepi.2004.08.021. J Clin Epidemiol. 2005. PMID: 16086467

9

The influence of display and statistical factors on the interpretation of metaanalysis results by physicians.

Raina PS, Brehaut JC, Platt RW, Klassen TP, Moher D, St John P, Bryant D, Viola R, Pham B. Raina PS, et al. Among authors: moher d. Med Care. 2005 Dec;43(12):1242-9. doi: 10.1097/01.mlr.0000185710.62071.7f. Med Care. 2005. PMID: 16299436 Clinical Trial.

10

Reporting randomized, controlled trials of herbal interventions: an elaborated CONSORT statement.

Gagnier JJ, Boon H, Rochon P, Moher D, Barnes J, Bombardier C; CONSORT Group. Gagnier JJ, et al. Among authors: moher d. Ann Intern Med. 2006 Mar 7;144(5):364-7. doi: 10.7326/0003-4819-144-5-200603070-00013. Ann Intern Med. 2006. PMID: 16520478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

906 results

Search Page

Filters